Combining next-generation gene sequencing technology with a bioinformatics platform, mainly targeted at genetically defined patients.
This report contains market size and forecasts of Commercialized Small Molecule for Therapy in Global, including the following market information:
Global Commercialized Small Molecule for Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Commercialized Small Molecule for Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tyrosine & Serine/Threonine Kinases Targeted Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Commercialized Small Molecule for Therapy include Bristol-Myers Squibb (BMY), Roche, Norvatis, AstraZeneca, Teva, Pfizer, Janssen Pharmaceutical (J & J), Sigma-Aldrich and Abbvie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Commercialized Small Molecule for Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Commercialized Small Molecule for Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Commercialized Small Molecule for Therapy Market Segment Percentages, by Type, 2021 (%)
Tyrosine & Serine/Threonine Kinases Targeted
Proteosomes Targeted
MMPs & HSPs Targeted
Apoptosis Targeted
Global Commercialized Small Molecule for Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Commercialized Small Molecule for Therapy Market Segment Percentages, by Application, 2021 (%)
Therapy
Relieve Symptoms
Global Commercialized Small Molecule for Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Commercialized Small Molecule for Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Commercialized Small Molecule for Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Commercialized Small Molecule for Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb (BMY)
Roche
Norvatis
AstraZeneca
Teva
Pfizer
Janssen Pharmaceutical (J & J)
Sigma-Aldrich
Abbvie
GSK
Bayer